Futurism logo

Review of 'The Crossing' 1.8

The Cure

By Paul LevinsonPublished 6 years ago 1 min read
Like

As seems to happen all too often when an announcement comes down that a series won't be renewed for another season, the remaining episodes just get better and better. If episode 1.8 on last night is any indication, that's just what's happened with The Crossing.

We already knew that Apex antibodies could cure and banish all kinds of ailments fatal to humanity. Last night we got a hint that Reece's antibodies can do something much more amazing. It was something that Naomi said about coming back from the dead. Maybe she was speaking metaphorically. But it got me thinking (always a dicey proposition): could Apex antibodies bring people back to life—people who had recently died? Like, for example, Emma—whose body, in pretty good shape albeit dead, turned up in this episode?

Even Jude pointed out that her body sure didn't look like it had been buried for days, and I had the feeling, when Emma was killed, that this wasn't the last we'd be seeing of her. Well, we did see her again last night—unfortunately, dead—but now it's less of a leap to see her revived. All that Jude has to do is get some of the infusions that Dr. Forbin will be preparing, get them into Emma, and... well, who knows?

At very least, this biological science fiction—of which my own Locus-Award-winning 1999 novel The Silk Code has been said to be an early example—is becoming almost as important in The Crossing as the time travel, and maybe more so. Which makes it all the more unfortunate that it's not being renewed.

So I'll join the chorus—or say it solo, if need be—hey, ABC, renew The Crossing. Or, if not, let some other network do this. Bring it back to life. It deserves a shot.

tv review
Like

About the Creator

Paul Levinson

Novels The Silk Code & The Plot To Save Socrates; LPs Twice Upon A Rhyme & Welcome Up; nonfiction The Soft Edge & Digital McLuhan, translated into 15 languages. Best-known short story: The Chronology Protection Case; Prof, Fordham Univ.

Reader insights

Be the first to share your insights about this piece.

How does it work?

Add your insights

Comments

There are no comments for this story

Be the first to respond and start the conversation.

Sign in to comment

    Find us on social media

    Miscellaneous links

    • Explore
    • Contact
    • Privacy Policy
    • Terms of Use
    • Support

    © 2024 Creatd, Inc. All Rights Reserved.